deliv anoth stellar quarter thank mako
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data oct
rate updat oct
currenc amount express
methodolog valu compani
stryker third-quart result demonstr well
firm meld smart strategi top-notch
execut year-to-d perform
consist track along expect
alter underli assumpt modestli
rais fair valu estim reflect cash flow realiz
sinc last updat continu fan stryker
wide moat though share consist trade
intrins valu past two half year
weve seen nine quarter grown
knee implant faster market primarili fuel
mako robot third quarter saw knee
rise johnson johnson knee fell
continu steadili place robot train
surgeon firm shi instal
robot notabl util rate grown year
year perhap intrigu hint one
publish prospect studi suggest compar
significantli decreas pain faster recoveri earli
discharg hospit anoth studi found mako
knee patient typic cost approxim less
treat less like use skill nurs follow
surgeri readmiss one third lower
non-mako patient preliminari indic
leav us optimist clinic econom
benefit mako favor data share
major orthoped confer march plan revisit
assumpt long-term mako placement
also continu see strength neurotechnolog
segment firm abl benefit
beefed-up product portfolio coil cathet well
grow adopt stent retriev ischem stroke
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
design manufactur market array medic equip
instrument consum suppli implant devic product
portfolio includ hip knee replac endoscopi system oper
room equip embol coil spinal devic remain one
three largest competitor reconstruct orthoped implant
hold leadership posit oper room equip approxim
total revenu current come outsid unit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
expect see low double-digit growth
final think stryker plan acquisit
savvi decis whole fan spine
market domin cater primari
patient degen spinal condit weve long
held clinic underpin mani commonli
perform spinal procedur shaki best
high-qual random control prospect
studi compar outcom procedur
studi exist suggest conserv
measur physic therapi may work well
invas spinal surgeri
howev squar aim complic spinal
market primarili compos moder sever
scoliosi patient pediatr adolesc adult
spine trauma mix clinic valu surgic
treatment type patient clear
significantli higher seen among
degen spinal patient thank foundat
clinic benefit reimburs well-establish
point addit immateri
financi standpoint howev view acquisit
anoth exampl manag team acut
discern
come
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
